Medicare ZepBound OSA Coverage Eligibility and Benefits Explained
Understanding ZepBound (Tirzepatide) and Its Role in Treating Obstructive Sleep Apnea (OSA) ZepBound, with the active ingredient tirzepatide, is a groundbreaking medication recently approved by the FDA for a novel use: treating obstructive sleep apnea (OSA) in adults with obesity. Traditionally recognized for its role in weight management, ZepBound expanded its indications in December 2024,…